Modulation of extracellular matrix components by metalloproteinases and their tissue inhibitors during degeneration and regeneration of rat sural nerve

Brain Research

Volumn 1122, Issue 1, 2006, Pages 36-46

  Gantus, M A V ^a   Nasciutti, L E ^a   Cruz, C M ^a   Persechini, P M ^a   Martinez, A M B ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Extracellular matrix (ECM); Metalloproteinases (MMP); Nerve regeneration; Peripheral nervous system; Tissue inhibitor of metalloproteinases (TIMP); Wallerian degeneration

Indexed keywords

CHONDROITIN SULFATE; COLLAGEN TYPE 4; LAMININ; LAMININ ALPHA2; LAMININ ALPHA3; MATRILYSIN; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; NERVE CRUSH; NERVE DEGENERATION; NERVE INJURY; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SURAL NERVE; WESTERN BLOTTING;

ANIMALS; COLLAGEN TYPE IV; EXTRACELLULAR MATRIX; LAMINS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 7; METALLOPROTEASES; NERVE CRUSH; NERVE DEGENERATION; NERVE REGENERATION; RATS; RATS, WISTAR; SURAL NERVE; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; WOUND HEALING;

WALLERIA;

EID: 33750743699     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.09.016     Document Type: Article

References (44)

1. Agapova O.A., Kaufman P.L., Lucarelli M.J., Gabelt B.A.T., and Hernandez M.R. Differential expression of matrix metalloproteinases in monkey eyes with experimental glaucoma or optic nerve transection. Brain Res. 967 (2003) 132-143
2. Ahmed Z., Dent R.G., Leadbeater W.E., Smith C., and Berry M.A. Matrix metalloproteases: degradation of the inhibitory environment of the transected optic nerve and the scar by regenerating axons. Mol. Cell. Neurosci. 28 (2005) 64-78
3. Anton E.S., Sandrock A.W.J.R., and Matthew W.D. Merosin promotes neurite growth and Schwann cell migration in vitro and nerve regeneration in vivo: evidence using an antibody to merosin, ARM-1. Dev. Biol. 164 (1994) 133-146
4. Bilousova T.V., Rusakov D.A., Ethell D.W., and Ethel I.M. Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation. J. Neurochem. 97 (2006) 44-56
5. Bode W., Fernandez-Catalan C., Grams F., Gomes-Rüth F.X., Nagase H., Tschesche H., and Maskos K. Insights into MMP-TIMP interactions. Ann. N. Y. Acad. Sci. 878 (1999) 73-91
6. Bradford M.M. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann. Biochem. 72 (1976) 248-254
7. Brew K., Deendayal D., and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochem. Biophys. Acta 1477 (2000) 267-283
8. Carey D.J., Eldridge C.F., Cornbooks C.J., Timl R., and Bunge R.P. Biosynthesis of type IV collagen by cultured rat Schwann cells. J. Cell Biol. 97 (1983) 473-479
9. Chen Z., and Strickland S. Laminin γ1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve. J. Cell Biol. 163 (2003) 889-899
10. Chernousov M.A., and Carey D.J. Schwann cell extracellular matrix molecules and their receptors. Histol. Histopathol. 15 (2000) 593-601
11. Demestre M., Wells G.M., Miller K.M., Smith K.J., Hughes R.A.C., Gearing A.J., and Gregson N.A. Characterization of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration. Neuroscience 124 (2004) 767-779
12. Doyu M., Sobue G., Ken E., Kimata K., Shinomura T., Yamada Y., Mitsuma T., and Takahashi A. Laminin A, B1, and B2 chain gene expression in transected and regenerating nerves: regulation by axonal signals. J. Neurochem. 60 (1993) 543-551
13. Ellis D.L., and Yannas I.V. Recent advances in tissue synthesis in vivo by use of collagen-glycosaminoglycan copolymers. Biomaterials 17 (1996) 291-299
14. Ferguson T.A., and Muir D. MMP-2 and MMP-9 increase the neurite-promoting potential of Schwann cell basal laminae and are upregulated in degenerated nerve. Mol. Cell. Neurosci. 16 (2000) 157-167
15. Fernandez-Valle C., Freigen N., Wood P.M., and Bunge M.B. Expression of the protein zero myelin gene in axon-related Schwann cells is linked to basal lamina formation. Developmental 119 (1993) 867-880
16. George E.B., Glass J.D., and Griffin J.W. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J. Neurosci. 10 (1995) 6445-6452
17. Hughes P.M., Wells G.M., Perry V.H., Brown M.C., and Miller K.M. Comparison of matrix metalloproteinase expression during Wallerian degeneration in the central and peripheral nervous systems. Neuroscience 113 (2002) 273-287
18. Jones L.L., Sajed D., and Tuszynski M.H. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition. J. Neurosci. 23 (2003) 9276-9288
19. Kim Y.S., Kim S.S., Cho J.J., Choi D.H., Hwang O., Shin D.H., Chun H.S., Beal M.F., and Joh T.H. Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglial. J. Neurosci. 25 (2005) 3701-3711
20. Labrador R.O., Buti M., and Navarro X. Influence of collagen and laminin gels concentration on nerve regeneration after resection and tube repair. Exp. Neurol. 149 (1998) 243-252
21. LaFleur M., Underwood J.L., Rappolee D.A., and Werb Z. Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J. Exp. Med. 184 (1996) 2311-2326
22. Malbouisson A.M.B., Ghabriel M.N., and Allt G. The non-directional pattern of axonal changes in Wallerian degeneration: a computer-linked quantitative analysis. J. Anat. 139 (1984) 159-174
23. Martinez A.M.B., and Ribeiro L.C.V. Ultrastructural localization of calcium in peripheral nerve fibres undergoing Wallerian degeneration: oxalate-pyroantimonate and X-ray microanalysis study. J. Submicrosc. Cytol. Pathol. 30 (1998) 451-458
24. Martini R. Expression and functional roles of neural cell surface molecules and extracellular matrix components during development and regeneration of peripheral nerves. J. Neurocytol. 23 (1994) 1-28
25. Misko A., Ferguson T., and Notterpek L. Matrix metalloproteinase mediated degradation of basement membrane proteins in Trembler J neuropathy nerves. J. Neurochem. 83 (2002) 885-894
26. Muir E.M., Adcock K.H., Morgenstern D.A., Clayton R., Von Stillfried N., Rhodes K., Ellis C., Fawcett J.W., and Rogers J.H. Matrix metalloproteinases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res. Mol. Brain Res. 100 (2002) 103-117
27. Murphy G., and Gavrilovic J. Proteolysis and cell migrating: creating a path?. Curr. Opin. Cell Biol. 11 (1999) 614-621
28. Murphy G., Knäuper V., Cowell S., Hembry R., Stanton H., Butler G., Frije J., Pendás A.M., and Lopez-Otín C. Evaluation of some newer matrix metalloproteinases. Ann. N. Y. Acad. Sci. 878 (1999) 25-39
29. Pérez-Martinez L., and Jaworki D.M. Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal. J. Neurosci. 25 (2005) 4917-4929
30. Podratz J.L., Rodriguez E., and Windebank A.J. Role of extracellular matrix in myelination of peripheral nerve. Glia 35 (2001) 35-40
31. Probstmeier R., Stichel C.C., Muller H.W., Asou H., and Pesheva P. Chondroitin sulfates expressed on oligodendrocyte-derived tenascin-R are involved in neural cell recognition. Functional implications during CNS development and regeneration. J. Neurosci. Res. 60 (2000) 21-36
32. Siironen J., Vuorio E., Sandberg M., and Roytta M. Expression of type I and III collagen and laminin beta1 after sciatic nerve crush injury. J. Peripher. Nerv. Syst. 3 (1996) 209-221
33. Snow D.M., Smith J.D., Cunningham A.T., McFarlin J., and Goshorn E.C. Neurite elongation on chondroitin sulfate proteoglycans is characterized by axonal fasciculation. Exp. Neurol. 182 (2003) 310-321
34. Stevens A., and Jacobs J.R. Integrins regulate responsiveness to slit repellent signals. J. Neurosci. 22 (2002) 4448-4455
35. Stoll G., and Müller H.W. Nerve injury, axonal degeneration and neural regeneration: basic insights. Brain Pathol. 9 (1999) 313-325
36. Stoll G., Griffin J.W., Li C.Y., and Trapp B.D. Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degeneration. J. Neurocytol. 18 (1989) 671-683
37. Stoll G., Jander S., and Myers R.R. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation. J. Peripher. Nerv. Syst. 7 (2002) 13-27
38. Timpl R., Wiedemann H., Van Delden V., Furthmayr H., and Kuhn K. A network model for the organization of type IV collagen molecules in basement membranes. Eur. J. Biochem. 120 (1981) 203-211
39. Tonge D.A., Golding J.P., Edbladh M., Kroon M., Ekstrom P.E., and Edstrom A. Effects of extracellular matrix components on axonal outgrowth from peripheral nerves of adult animals in vitro. Exp. Neurol. 146 (1997) 81-90
40. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure, function, and biochemistry. Circ. Res. 92 (2003) 827-839
41. Vogelezang M.G., Scherer S.S., and Fawcett J.W. Regulation of fibronectin alternative splicing during peripheral nerve repair. J. Neurosci. Res. 56 (1999) 323-333
42. Vos C.M.P., Gartner S., Ransohoff R.M., McArthur J.C., Wahl L., Sjulon L., Hunter E., and Conant K. Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration. J. Neuroimmunol. 109 (2000) 221-227
43. Zuo J., Ferguson T.A., Hernandez Y.J., Stetler-Stevenson W.G., and Muir D. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J. Neurosci. 18 (1998) 5203-5211
44. Zuo J., Hernandez Y.J., and Muir D. Chondroitin sulfate proteoglycan with neurite-inhibiting activity is upregulated following peripheral nerve injury. J. Neurobiol. 34 (1998) 41-54